Inhibiting Cholesterol-associated Protein Reduces High-risk Blockages In Arteries
Saturday, September 27, 2008 - 19:21
in Health & Medicine
Using the drug darapladib, researchers have inhibited a cholesterol-and immune system-associated protein, thereby reducing the development of heart-disease plaques that may cause death, heart attacks, and strokes in a pig model of atherosclerosis and diabetes.
Read the whole article on Science Daily
More from Science Daily
Related
- Inhibiting cholesterol-associated protein reduces high-risk blockages in arteriesMon, 22 Sep 2008, 16:08:58 EDT
- When statins aren't enough: New trial drug points to better management of coronary heart diseaseThu, 8 May 2008, 14:22:20 EDT
- Bundling 2 low-cost heart drugs prevents heart attack and stroke in large, diverse populationThu, 1 Oct 2009, 19:00:46 EDT
- Moms who breastfeed less likely to develop heart attacks or strokesTue, 21 Apr 2009, 0:28:55 EDT
- Prostaglandin receptor key to atherosclerosis developmentMon, 15 Dec 2008, 14:22:41 EST